Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To provide the significance of LDH isozymes in rat CNS tumors, the changes in lactic dehydrogenase isozyme and calculated ratios of H- to M- subunit were studied by means of polyacrylamide gel enzymoelectrophoresis in tumor extracts from CNS tumors (7 astrocytomas, 4 oligodendrogliomas, 7 mixed gliomas, 6 anaplastic gliomas, 3 glioependymomas, 1 astroblastoma, 11 neurinomas, 8 anaplastic neurinomas and 1 meningioma in Wistar rats which were induced by ethylnitrosourea). The isozyme patterns were compared to those obtained from normal rat CNS tissues. Among the
glioma
group, oligodendroglioma showed the highest H/M ratio followed by mixed
glioma
, glioependymoma, astrocytoma, astroblastoma and anaplastic
glioma
in order of decreasing of H/M ratios. On the other hand, the H/M ratio of
neurinoma
was significantly higher than that of anaplastic
neurinoma
. These observation suggested that determination of LDH isozyme patterns could supplement the histological evaluation of brain tumors.
...
PMID:LDH isozyme analyses of ethylnitrosourea-induced central nervous system tumors in rats. 739 14
We report a case of astrocytoma of the acoustic nerve. Most gliomas arise from the brainstem, and seldom originate in the acoustic or other "true" cranial and spinal nerves. Clinical features of this rare acoustic tumor differ from those of brainstem gliomas, but are indistinguishable from typical acoustic neurilemoma. We discuss the diagnosis and histogenesis of
glioma
arising in the eighth cranial nerve. Demonstration of glial fibrillary acid protein, an antigen specific for astrocytes, is a new method of verifying the diagnosis. Review of the literature indicates that a few cases of epithelial-like tumors of peripheral nerves may have been of neuroepithelial origin. The evidence, however, generally is not sufficient to exclude the possibility of metastatic neoplasms or other tumors such as malignant
schwannoma
and melanoma. Most of these putative gliomas contained gland-like tissue, and did not have the morphologic appearance of astrocytoma, as in approximately five reported examples, and in our case.
...
PMID:Glioma of the acoustic nerve. 739 89
Twenty cases which showed partial loss of ABR waves were reported. Only wave I was recorded in 18 ears tested. Wave I and II; I-III; and I-IV responses were observed in four, eight, and five ears tested, respectively. Cases included pontine
glioma
(8), acoustic tumor (4), West syndrome (2), leukodystrophy (2), facial
neurinoma
(1), epidermoid tumor (1), pontine bleeding (1), and unknown cause (1). Fourteen of 20 were tumor cases. This fact indicates that if the ABR shows partial loss of waves, the examiner should first suspect the space-occupying lesions of the brain stem.
...
PMID:A study of cases with partial disappearance of the waves in the auditory brain stem response. 745 58
The use of superdelayed thallium-201 single photon emission computed tomography (201Tl SPECT) for differentiating malignant gliomas from cerebral metastases was investigated in 23 patients (7 with meningioma, 6 with
glioma
, 7 with cerebral metastasis, 1 with each of
neurinoma
, abscess, and necrosis). 4 mCi of 201Tl was injected intravenously, and gamma camera scans were performed after 10 minutes and 4, 24, 72, and 96 hours (superdelayed scan). The mean thallium index of meningiomas was significantly higher than those of gliomas and cerebral metastases after 10 minutes, while the mean thallium indices of meningiomas and gliomas were significantly higher than those of cerebral metastases after 96 hours. The combination of early and superdelayed 201Tl SPECT may be useful in differentiating malignant gliomas from cerebral metastases.
...
PMID:Differentiation of malignant glioma and metastatic brain tumor by thallium-201 single photon emission computed tomography. 752 48
Diffusion-weighted magnetic resonance imaging was used for the description of experimental brain tumors in rat. To validate this approach, diffusion-weighted images (DWI) were compared with native T1- and T2-weighted images, and with T1-weighted images following contrast enhancement with the tumor-specific contrast agent manganese (III) tetraphenylporphine sulfonate (MnTPPS). Three tumor types were studied: F98
glioma
, RN6
Schwannoma
, and E376 neuroblastoma. On heavily diffusion-weighted images, all three tumor types as well as the peritumoral edema were clearly hypointense with respect to the intact brain tissue. T2-weighted images presented mainly peritumoral edema as hyperintense region. A clear demarcation of the tumor was possible only on T1-weighted images after contrast enhancement with MnTPPS. The difference in signal intensity between tumor and homotopic regions in the contralateral hemisphere was comparable in DWIs and in contrast-enhanced T1-weighted images. Spatial comparison of depicted lesion areas in all three imaging modalities indicated that hypointense region on DWI represents both tumor and edema but does not permit their spatial differentiation.
...
PMID:Diffusion-weighted MR imaging of experimental brain tumors in rats. 760 Jan 72
Transfrontal approach is the way available for microsurgical removal of retrobulbar tumor. The tumor can be completely extirpated with minimal injury upon the optic nerve, oculomotor nerve, ciliary ganglion and ophthalmic vessels as well as ocular muscles. Thirty-two cases of retrobulbar tumor (cavernous hemangioma, telangioma,
glioma
, lymphangioma,
neurinoma
, neurofibroma and rhabdomyosarcoma) were operated through this approach with microsurgical techniques. Follow-up shows that in all cases no recurrence occurs in 3-9 years and reveals that in 29 cases the preservation or functional recovery of vision and ocular movement are satisfied. One case of rhadomyosarcoma and two cases of
glioma
lose their vision for the partial resection of optic nerve which was invaded by the tumor. It is useful to detect undesirable dissection of tumors from its surrounding oculomotor nerves with evoked potential monitoring.
...
PMID:[Transfrontal approach for the microsurgery of retrobulbar tumor]. 774 23
Chromatin condensation during apoptosis induced by TGF beta 1 in T24
glioma
and 476-16 trigeminal
neurinoma
(
Schwannoma
) cells was examined and compared with that occurring during mitosis. Apoptotic (round-up) cells were selectively detached from the culture surface by a mechanical shock. Their histones were analysed in comparison with those obtained from TGF beta 1-treated cells remaining attached to the culture surface, from control cells not treated with TGF beta 1 and from metaphase cells. While mitosis-specific hyperphosphorylation of histones H1 and phosphorylation of histone H3 was not observed in apoptotic cells, apoptotic chromatin lacked ubiquitinated histone H2A (histone uH2A) as did metaphase chromosomes. The cellular level of free ubiquitin and the overall pattern of ubiquitin-conjugated proteins were, however, found to remain unaltered in apoptotic cells, suggesting that the ubiquitin conjugating machinery for histone H2A may be specifically perturbed during the chromatin condensation occurring in apoptosis.
...
PMID:Disappearance of ubiquitinated histone H2A during chromatin condensation in TGF beta 1-induced apoptosis. 776 93
The ability of proton magnetic resonance spectroscopy (1H MRS) to diagnose brain tumors was investigated using in vitro high-resolution spectra. Fifty-eight surgically excised samples of brain tumors (12 glioblastomas, 4 anaplastic astrocytomas, 6 astrocytomas, 12 meningiomas, 6 neurinomas, 4 chordomas, 3 craniopharyngiomas, 2 pituitary adenomas, 2 malignant lymphomas, 1 ependymoma, 1 medulloblastoma, and metastatic brain tumors including 3 pulmonary adenocarcinomas, a hepatocellular carcinoma, and a renal cell carcinoma) and 4 nontumorous lobectomized brains were examined by in vitro 1H MRS. N-Acetyl-aspartate was demonstrated in normal tissues but could not be detected in nonneuroectodermal tumors. Total creatine was decreased in all brain tumors in comparison with normal brain tissues, but was relatively higher in neuroectodermal tumors than in other brain tumors. Choline-containing compounds were present in all tumors except craniopharyngioma, and their concentrations were particularly high in a metastatic brain tumor from hepatocellular carcinoma. The concentration of glycine was high in neuroectodermal tumors, whereas that of taurine was high in medulloblastoma, pituitary adenoma, and renal cell carcinoma. Alanine was increased in meningioma,
glioma
, and pituitary adenoma.
Neurinoma
had the largest inositol content among the tumors examined. Thus each type of brain tumor exhibited a characteristic MR spectrum. These data suggested that in vivo 1H MRS might provide clinically useful information about tumor metabolism and aid in the differential diagnosis of tumors. Although excellent anatomical localization of tumors can be readily obtained by MR imaging, MRS may provide additional information in cases in which the differential diagnosis of tumors by MR imaging is difficult.
...
PMID:Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. 780 3
The in vivo relaxation times T1 and T2 were quantitatively determined in rat brain. Animals with implanted experimental brain tumors were investigated for discrimination of pathological regions from normal brain structures based on relaxation time differences. The different cerebral tumors (
glioma
,
schwannoma
, neuroblastoma) showed no difference in relaxation times, but all tumors had T1(1301 +/- 167 ms) and T2(91 +/- 9 ms) times distinctly longer than normal brain (T1: 1057 +/- 77 ms; T2: 77 +/- 6 ms). T1 can be used for distinction of tumor and edema from normal brain, while T2 is the better parameter for discrimination between tumor and edema. Furthermore, the effect of MRI contrast agents (GdDTPA, MnTPPS, GdTPPS) on the relaxation times of these experimental brain tumors was measured. The enhancement of tumors produced by GdDTPA disappeared within ten minutes after i.p. application. At later times, central cysts and peritumoral edema became the most enhanced structures. The enhancement of tumor following MnTPPS application remained unchanged in T1-weighted images during the whole observation period of four days. A significant reduction of enhancement was not observed during this time. The effect of MnTPPS on T2 was weak. Replacement of manganese with gadolinium as the central ion of the porphyrin TPPS led to a contrast agent with enhancement effects on both, T1- and T2-weighted images.
...
PMID:Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues. 784 9
All previous studies of the localization of utrophin (the dystrophin-related protein) in muscle and other tissues have been performed only with antibodies against the C-terminal region of the protein. Since several short forms of dystrophin, the apo-dystrophins, are produced from the 3' end of the dystrophin gene, there is a possibility that similar short forms of utrophin exist and that these could be responsible for some of the many different localizations of 'utrophin' in muscle. We have produced a new panel of 15 mAbs against the N-terminal region of utrophin and we have used it together with mAbs against the C-terminal region to show that full-length utrophin is present at neuromuscular junctions, in nerves, blood vessels and capillaries in normal muscle and in the sarcolemma of patients with muscular dystrophy and dermatomyositis. However, two of the 15 mAbs also recognised rat/mouse utrophin and both of these detected an additional 62 kDa protein on Western blots of rat C6
glioma
cells. This potential 62 kDa 'apo-utrophin' was not detected in human cerebral cortex, in rat
Schwannoma
cells nor in any of the non-nerve cells and tissues tested.
...
PMID:Full-length and short forms of utrophin, the dystrophin-related protein. 784 13
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>